These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 37089569)
41. First nationwide study regarding ceftriaxone resistance and molecular epidemiology of Neisseria gonorrhoeae in China. Chen SC; Yin YP; Dai XQ; Unemo M; Chen XS J Antimicrob Chemother; 2016 Jan; 71(1):92-9. PubMed ID: 26472770 [TBL] [Abstract][Full Text] [Related]
42. Genomic epidemiology and antimicrobial resistance determinants of Neisseria gonorrhoeae isolates from Ukraine, 2013-2018. Boiko I; Golparian D; Jacobsson S; Krynytska I; Frankenberg A; Shevchenko T; Unemo M APMIS; 2020 Jul; 128(7):465-475. PubMed ID: 32441045 [TBL] [Abstract][Full Text] [Related]
43. Monitoring antimicrobial resistance in Neisseria gonorrhoeae in selected countries of the WHO South-East Asia Region between 2009 and 2012: a retrospective analysis. Bala M; Kakran M; Singh V; Sood S; Ramesh V; Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv28-35. PubMed ID: 24243876 [TBL] [Abstract][Full Text] [Related]
44. Canary in the Coal Mine: How Resistance Surveillance in Commensals Could Help Curb the Spread of AMR in Pathogenic Goytia M; Wadsworth CB mBio; 2022 Oct; 13(5):e0199122. PubMed ID: 36154280 [TBL] [Abstract][Full Text] [Related]
45. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from symptomatic men attending the Nanjing sexually transmitted diseases clinic (2011-2012): genetic characteristics of isolates with reduced sensitivity to ceftriaxone. Li S; Su XH; Le WJ; Jiang FX; Wang BX; Rice PA BMC Infect Dis; 2014 Nov; 14():622. PubMed ID: 25427572 [TBL] [Abstract][Full Text] [Related]
46. The first year of the global Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) in Bangkok, Thailand, 2015-2016. Sirivongrangson P; Girdthep N; Sukwicha W; Buasakul P; Tongtoyai J; Weston E; Papp J; Wi T; Cherdtrakulkiat T; Dunne EF; PLoS One; 2018; 13(11):e0206419. PubMed ID: 30412586 [TBL] [Abstract][Full Text] [Related]
47. First characterisation of antimicrobial susceptibility and resistance of Neisseria gonorrhoeae isolates in Qatar, 2017-2020. Al-Maslamani M; Elmagboul EBI; Puthiyottil A; Chemaitelly H; Varghese MK; Al Romaihi HE; Al-Thani MH; Al Khal A; Unemo M; Abu-Raddad LJ PLoS One; 2022; 17(3):e0264737. PubMed ID: 35235608 [TBL] [Abstract][Full Text] [Related]
48. Antimicrobial susceptibility testing and molecular characterization of Zolfaghari P; Emamie AD; Rajabpour M; Zarei A; Whiley DM; Pourmand MR; Pourmand G Int J STD AIDS; 2022 Jun; 33(7):660-665. PubMed ID: 35485393 [TBL] [Abstract][Full Text] [Related]
49. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from Hefei (2014-2015): genetic characteristics of antimicrobial resistance. Jiang FX; Lan Q; Le WJ; Su XH BMC Infect Dis; 2017 May; 17(1):366. PubMed ID: 28545411 [TBL] [Abstract][Full Text] [Related]
50. Summary and Trends of the Russian Gonococcal Antimicrobial Surveillance Programme, 2005 to 2016. Kubanov A; Solomka V; Plakhova X; Chestkov A; Petrova N; Shaskolskiy B; Dementieva E; Leinsoo A; Gryadunov D; Deryabin D J Clin Microbiol; 2019 Jun; 57(6):. PubMed ID: 30894437 [TBL] [Abstract][Full Text] [Related]
51. Antimicrobial Susceptibility Testing Patterns of Aboud S; Buhalata SN; Onduru OG; Chiduo MG; Kwesigabo GP; Mshana SE; Manjurano AM; Temu MM; Kishamawe C; Changalucha JM Trop Med Infect Dis; 2022 Jun; 7(6):. PubMed ID: 35736968 [TBL] [Abstract][Full Text] [Related]
52. Trends in antimicrobial resistance in Neisseria gonorrhoeae in Hanoi, Vietnam, 2017-2019. Adamson PC; Van Le H; Le HHL; Le GM; Nguyen TV; Klausner JD BMC Infect Dis; 2020 Nov; 20(1):809. PubMed ID: 33153450 [TBL] [Abstract][Full Text] [Related]
53. Antimicrobial Resistance Mechanisms, Multilocus Sequence Typing, and NG-STAR Sequence Types of Diverse Neisseria gonorrhoeae Isolates in KwaZulu-Natal, South Africa. Mitchev N; Singh R; Allam M; Kwenda S; Ismail A; Garrett N; Ramsuran V; Niehaus AJ; Mlisana KP Antimicrob Agents Chemother; 2021 Sep; 65(10):e0075921. PubMed ID: 34280016 [TBL] [Abstract][Full Text] [Related]
54. Current and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challenge. Unemo M BMC Infect Dis; 2015 Aug; 15():364. PubMed ID: 26293005 [TBL] [Abstract][Full Text] [Related]
55. External quality assessment (EQA) of Neisseria gonorrhoeae antimicrobial susceptibility testing in primary laboratories in Germany. Selb R; Jansen K; Eckardt M; Tamminga T; Dudareva S; Gassowski M; Graeber I; Guhl E; Heuer D; Buder S; BMC Infect Dis; 2020 Jul; 20(1):514. PubMed ID: 32677988 [TBL] [Abstract][Full Text] [Related]
56. National surveillance of Machado HM; Martins JM; Schörner MA; Gaspar PC; Bigolin A; Ramos MC; Ferreira WA; Pereira GFM; Miranda AE; Unemo M; Bazzo ML; JAC Antimicrob Resist; 2022 Aug; 4(4):dlac076. PubMed ID: 35795244 [TBL] [Abstract][Full Text] [Related]
58. Antimicrobial Susceptibility of Melendez JH; Hardick J; Barnes M; Page KR; Gaydos CA Antibiotics (Basel); 2018 Aug; 7(3):. PubMed ID: 30126088 [TBL] [Abstract][Full Text] [Related]
59. Biomedical Response to Neisseria gonorrhoeae and Other Sexually Transmitted Infections in the US Military. Garges E; Early J; Waggoner S; Rahman N; Golden D; Agan B; Jerse A Mil Med; 2019 Nov; 184(Suppl 2):51-58. PubMed ID: 31778198 [TBL] [Abstract][Full Text] [Related]
60. Genomic surveillance and antimicrobial resistance in Neisseria gonorrhoeae isolates in Bangkok, Thailand in 2018. Golparian D; Kittiyaowamarn R; Paopang P; Sangprasert P; Sirivongrangson P; Franceschi F; Jacobsson S; Wi T; Unemo M J Antimicrob Chemother; 2022 Jul; 77(8):2171-2182. PubMed ID: 35542983 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]